Extendicare Inc (TSE:EXE) is scheduled to release its earnings data after the market closes on Thursday, November 9th.

Extendicare Inc (TSE EXE) opened at C$9.46 on Wednesday. Extendicare Inc has a 52 week low of C$8.73 and a 52 week high of C$10.75.

The company also recently disclosed a monthly dividend, which was paid on Monday, October 16th. Stockholders of record on Friday, September 29th were paid a $0.04 dividend. This represents a $0.48 annualized dividend and a dividend yield of 5.07%. The ex-dividend date of this dividend was Thursday, September 28th.

In other news, Director Alan Roy Hibben acquired 5,000 shares of the stock in a transaction dated Friday, August 11th. The stock was bought at an average price of C$9.07 per share, with a total value of C$45,350.00. Also, Director Timothy Louis Lukenda acquired 100,000 shares of the stock in a transaction dated Monday, September 18th. The stock was purchased at an average cost of C$9.23 per share, with a total value of C$923,000.00. Insiders bought 106,600 shares of company stock valued at $983,272 in the last ninety days.

COPYRIGHT VIOLATION NOTICE: This article was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/11/08/extendicare-inc-exe-set-to-announce-earnings-on-thursday.html.

Extendicare Company Profile

Extendicare Inc provides senior care services in Canada. It offers long term care services; retirement living care services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities. The company also provides third party liability insurance products in the United States.

Receive News & Stock Ratings for Extendicare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare Inc and related stocks with our FREE daily email newsletter.